Cargando…
Yield and costs of molecular diagnostics on thyroid cytology slides in the Netherlands, adapting the Bethesda classification
OBJECTIVE: To evaluate our institutional experience with molecular diagnostics (MD) on thyroid cytology smears, evaluate the costs and describe MD guided clinical management of indeterminate Bethesda III/V thyroid nodules. METHODS: We performed a retrospective review of 164 Bethesda III or V thyroid...
Autores principales: | Aydemirli, Mehtap Derya, Snel, Marieke, van Wezel, Tom, Ruano, Dina, Obbink, Christianne M. H., van den Hout, Wilbert B., Schepers, Abbey, Morreau, Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502216/ https://www.ncbi.nlm.nih.gov/pubmed/34505415 http://dx.doi.org/10.1002/edm2.293 |
Ejemplares similares
-
Targeted Treatment Options of Recurrent Radioactive Iodine Refractory Hürthle Cell Cancer
por: Aydemirli, Mehtap Derya, et al.
Publicado: (2019) -
Targeting EML4-ALK gene fusion variant 3 in thyroid cancer
por: Aydemirli, Mehtap Derya, et al.
Publicado: (2021) -
A clinically applicable molecular classification of oncocytic cell thyroid nodules
por: de Koster, Elizabeth J, et al.
Publicado: (2023) -
The Bethesda System for reporting cervical cytology
por: Pangarkar, Meena A.
Publicado: (2022) -
Second edition of 'The Bethesda System for reporting cervical cytology' – atlas, website, and Bethesda interobserver reproducibility project
por: Nayar, Ritu, et al.
Publicado: (2004)